NYX-2925

DRUG4 trials

Sponsors

Aptinyx

Conditions

Diabetic Peripheral NeuropathyFibromyalgiaHealthy Volunteers

Phase 1

Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers

CompletedNCT02834741

AptinyxHealthy Volunteers

Start: 2016-07-31End: 2017-03-31Updated: 2017-04-05

Phase 2

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

CompletedNCT03219320

AptinyxDiabetic Peripheral Neuropathy

Start: 2017-06-27End: 2018-11-02Updated: 2020-06-09

Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

CompletedNCT03249103

AptinyxFibromyalgia

Start: 2017-08-14End: 2019-04-18Updated: 2022-09-16

Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

CompletedNCT04147858

AptinyxFibromyalgia

Start: 2019-11-12End: 2022-06-16Updated: 2023-04-28